These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35776759)

  • 1. Azithromycin possesses biofilm-inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia.
    Moshynets OV; Baranovskyi TP; Cameron S; Iungin OS; Pokholenko I; Jerdan R; Kamyshnyi A; Krikunov AA; Potochilova VV; Rudnieva KL; Spiers AJ
    PLoS One; 2022; 17(7):e0270983. PubMed ID: 35776759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.
    Lin L; Nonejuie P; Munguia J; Hollands A; Olson J; Dam Q; Kumaraswamy M; Rivera H; Corriden R; Rohde M; Hensler ME; Burkart MD; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2015 Jul; 2(7):690-8. PubMed ID: 26288841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro interactions of combinations of colistin with meropenem, rifampicin and tigecycline in colistin-resistant, biofilm-forming Klebsiella pneumoniae.
    Müderris T; Dursun Manyaslı G; Kaya S; Gül Yurtsever S
    Diagn Microbiol Infect Dis; 2024 Oct; 110(2):116408. PubMed ID: 39079190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of polymyxin B activity in Klebsiella pneumoniae biofilm.
    Herrera KMS; Silva FKD; Oliveira ME; Paiva MC; Soares AC; Siqueira Ferreira JM
    J Chemother; 2019 May; 31(3):127-131. PubMed ID: 30661470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms.
    Silva A; Sousa AM; Alves D; Lourenço A; Pereira MO
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27140200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant
    Sturaro MC; Damaceno NdS; Faccin ID; Silva ON; de Aquino TM; Freire NML; Alcântara MGdS; Monteiro KLC; Rossato L; de Souza GHdA; Simionatto S
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0093024. PubMed ID: 39254296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections.
    Shein AMS; Wannigama DL; Higgins PG; Hurst C; Abe S; Hongsing P; Chantaravisoot N; Saethang T; Luk-In S; Liao T; Nilgate S; Rirerm U; Kueakulpattana N; Laowansiri M; Srisakul S; Muhummudaree N; Techawiwattanaboon T; Gan L; Xu C; Kupwiwat R; Phattharapornjaroen P; Rojanathanes R; Leelahavanichkul A; Chatsuwan T
    Sci Rep; 2021 Nov; 11(1):21676. PubMed ID: 34737361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
    Borjan J; Meyer KA; Shields RK; Wenzler E
    Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.
    Richter SS; Karichu J; Otiso J; Van Heule H; Keller G; Cober E; Rojas LJ; Hujer AM; Hujer KM; Marshall S; Perez F; Rudin SD; Domitrovic TN; Kaye KS; Salata R; van Duin D; Bonomo RA
    Diagn Microbiol Infect Dis; 2018 May; 91(1):89-92. PubMed ID: 29456071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae.
    Ren H; Zhang J; Zhou J; Xu C; Fan Z; Pan X; Li S; Liang Y; Chen S; Xu J; Wang P; Zhang Y; Zhu G; Liu H; Jin Y; Bai F; Cheng Z; Pletzer D; Wu W
    J Antibiot (Tokyo); 2021 Aug; 74(8):528-537. PubMed ID: 34050325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the in vitro activity of azithromycin niosomes alone and in combination with levofloxacin on extensively drug-resistant Klebsiella pneumoniae clinical isolates.
    Owais HM; Baddour MM; El-Metwally HAE; Barakat HS; Ammar NS; Meheissen MA
    Braz J Microbiol; 2021 Jun; 52(2):597-606. PubMed ID: 33483896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.
    Pitt ME; Cao MD; Butler MS; Ramu S; Ganesamoorthy D; Blaskovich MAT; Coin LJM; Cooper MA
    J Antimicrob Chemother; 2019 Mar; 74(3):582-593. PubMed ID: 30445429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
    Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
    Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009).
    Sader HS; Farrell DJ; Jones RN
    Int J Antimicrob Agents; 2011 Feb; 37(2):174-5. PubMed ID: 21123034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.